Viewing Study NCT00280969


Ignite Creation Date: 2025-12-24 @ 10:56 PM
Ignite Modification Date: 2026-03-05 @ 6:58 PM
Study NCT ID: NCT00280969
Status: COMPLETED
Last Update Posted: 2015-03-30
First Post: 2006-01-22
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Comparing the Effectiveness Between Ritonavir Boosted Atazanavir and Efavirenz for the First HIV Treatment
Sponsor: International Medical Center of Japan
Organization:

Organization Data

Organization:
Class: OTHER_GOV
Study ID: QD001
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER_GOV
Responsible Party:
Responsible Party Title:
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER_GOV View